IP Library Granted Patent US 8,324,345
Granted Patent B2
US 8,324,345 · App. 12/444,988 · Granted Dec 4, 2012

HLA-binding peptide, precursor thereof, DNA fragment and recombinant vector encoding the same

Assignees: NEC Corporation; Kochi University
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,324,345
App. No.
12/444,988
Granted
Dec 4, 2012
Kind
B2
Abstract

There is provided an HLA-binding peptide being excellent in binding affinity to an HLA-A type molecule. An HLA-binding peptide capable of binding to an HLA-A type molecule, including one or more amino acid sequences selected from the group consisting of SEQ ID NOs: 1 to 50, and being composed of 8 or more and 11 or less amino acid residues, is provided. All of the amino acid sequences are the amino acid sequences that are predicted to be capable of binding to an HLA-A molecule by using a prediction program utilizing an active learning method shown in FIG. 1.

Claims (7)

1. An HLA-binding peptide capable of binding to an HLA-A type molecule, characterized in that the peptide comprises the amino acid sequence of SEQ ID NO: 15, and wherein said HLA-binding peptide is composed of 11 or less amino acid residues.

2. An HLA-binding peptide capable of binding to an HLA-A type molecule, characterized in that the peptide comprises the amino acid sequence of SEQ ID NO: 15 in which one amino acid residue has been deleted, substituted or added and wherein said HLA-binding peptide is composed of 8 or more and 11 or less amino acid residues.

3. The HLA-binding peptide according to claim 1 , characterized in that the HLA-binding peptide binds to an HLA-A24 molecule.

4. The HLA-binding peptide according to claim 3 , wherein the HLA-A24 molecule is an HLA-A2402 molecule.

5. The HLA-binding peptide according to claim 1 , characterized in that the HLA-binding peptide binds to an HLA-A2 molecule.

6. The HLA-binding peptide according to claim 5 , wherein the HLA-A2 molecule is an HLA-A0201 molecule.

7. The HLA-binding peptide according to claim 5 , wherein the HLA-A2 molecule is an HLA-A0206 molecule.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 9, 2009
From: MIYAKAWA, TOMOYA; UDAKA, KEIKO
To: NEC CORPORATION; KOCHI UNIVERSITY
Reel/Frame 022527/0467 →
Priority Claims (2)
JP 2006-279232 · Oct 12, 2006 · national
JP 2007-189047 · Jul 20, 2007 · national
Continuity (1)
Related Publication 20100144025A1 · Jun 10, 2010